Tenax Therapeutics (TENX) Current Assets (2011 - 2026)

Tenax Therapeutics (TENX) has 15 years of Current Assets data on file, last reported at $123.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 9.92% year-over-year to $123.2 million; the trailing twelve-month figure through Mar 2026 stood at $123.2 million (up 9.92% YoY), and the FY2025 full-year result was $104.2 million, up 7.8% from the prior year.
• Current Assets improved to $123.2 million in Q1 2026, from $104.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $123.2 million in Q1 2026 to a low of $3.2 million in Q4 2022.
• A 5-year average of $49.5 million and a median of $14.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 47.41% in 2022 and jumped 897.17% in 2025, its largest moves.
• Tracing TENX's Current Assets over 5 years: stood at $3.2 million in 2022, then jumped by 264.16% to $11.7 million in 2023, then soared by 727.51% to $96.7 million in 2024, then rose by 7.8% to $104.2 million in 2025, then increased by 18.18% to $123.2 million in 2026.
• Business Quant data shows TENX's Current Assets at $123.2 million in Q1 2026, $104.2 million in Q4 2025, and $102.8 million in Q3 2025.